恶性肿瘤中分泌蛋白的研究进展
Research advances of secretory proteins in malignant tumors.
作者信息
Zhang Na, Hao Jiajie, Cai Yan, Wang Mingrong
机构信息
State Key Laboratory of Molecular Oncology, Center for Cancer Precision Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
出版信息
Chin J Cancer Res. 2021 Feb 28;33(1):115-132. doi: 10.21147/j.issn.1000-9604.2021.01.12.
Abstract
Secretory proteins in tumor tissues are important components of the tumor microenvironment. Secretory proteins act on tumor cells or stromal cells or mediate interactions between tumor cells and stromal cells, thereby affecting tumor progression and clinical treatment efficacy. In this paper, recent research advances in secretory proteins in malignant tumors are reviewed.
摘要
肿瘤组织中的分泌蛋白是肿瘤微环境的重要组成部分。分泌蛋白作用于肿瘤细胞或基质细胞，或介导肿瘤细胞与基质细胞之间的相互作用，从而影响肿瘤进展和临床治疗效果。本文综述了恶性肿瘤中分泌蛋白的最新研究进展。
相似文献
1
Research advances of secretory proteins in malignant tumors.恶性肿瘤中分泌蛋白的研究进展
Chin J Cancer Res. 2021 Feb 28;33(1):115-132. doi: 10.21147/j.issn.1000-9604.2021.01.12.
2
Tumor microenvironment and the role of mesenchymal stromal cells.肿瘤微环境与间充质基质细胞的作用。
Neoplasma. 2013;60(1):1-10. doi: 10.4149/neo_2013_001.
3
Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.肿瘤-基质相互作用指导上皮性皮肤肿瘤细胞的表型和进展。
Differentiation. 2002 Dec;70(9-10):486-97. doi: 10.1046/j.1432-0436.2002.700903.x.
4
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer.理解乳腺癌肿瘤基质介导的化疗耐药性的最新进展。
Mol Cancer. 2019 Mar 30;18(1):67. doi: 10.1186/s12943-019-0960-z.
5
The role of tumor microenvironment in therapeutic resistance.肿瘤微环境在治疗耐药性中的作用。
Oncotarget. 2017 Jan 17;8(3):3933-3945. doi: 10.18632/oncotarget.13907.
6
Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.用于癌症诊疗的靶向和重塑肿瘤微环境的纳米颗粒
J Biomed Nanotechnol. 2018 Jul 1;14(7):1189-1207. doi: 10.1166/jbn.2018.2546.
7
Chemotherapy and tumor microenvironment of pancreatic cancer.胰腺癌的化疗与肿瘤微环境
Cancer Cell Int. 2017 Jul 5;17:68. doi: 10.1186/s12935-017-0437-3. eCollection 2017.
8
Shaping of the tumor microenvironment: Stromal cells and vessels.肿瘤微环境的塑造：基质细胞与血管。
Semin Cancer Biol. 2015 Oct;34:3-13. doi: 10.1016/j.semcancer.2015.03.002. Epub 2015 Mar 18.
9
Malignant transformation of host stromal fibroblasts derived from the bone marrow traced in a dual-color fluorescence xenograft tumor model.在双色荧光异种移植肿瘤模型中追踪源自骨髓的宿主基质成纤维细胞的恶性转化。
Oncol Rep. 2015 Dec;34(6):2997-3006. doi: 10.3892/or.2015.4281. Epub 2015 Sep 17.
10
[Recent research advance on bone marrow microenvironment-mediated leukemia drug resistant mechanism].[骨髓微环境介导白血病耐药机制的研究新进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):848-50.
引用本文的文献
1
Cancer cells impact the microrheology of endothelial cells during physical contact or through paracrine signalling.癌细胞在物理接触过程中或通过旁分泌信号传导影响内皮细胞的微观流变学。
Sci Rep. 2025 Mar 8;15(1):8064. doi: 10.1038/s41598-025-92422-w.
2
Ribonuclease 1 Induces T-Cell Dysfunction and Impairs CD8 T-Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1.核糖核酸酶1通过劫持信号转导和转录激活因子1诱导T细胞功能障碍并损害CD8+ T细胞的细胞毒性，从而促进肿瘤生长。
Adv Sci (Weinh). 2025 Apr;12(13):e2404961. doi: 10.1002/advs.202404961. Epub 2025 Feb 11.
3
Identifying Key Genes as Progression Indicators of Prostate Cancer with Castration Resistance Based on Dynamic Network Biomarker Algorithm and Weighted Gene Correlation Network Analysis.基于动态网络生物标志物算法和加权基因共表达网络分析鉴定关键基因作为去势抵抗性前列腺癌进展的指标
Biomedicines. 2024 Sep 23;12(9):2157. doi: 10.3390/biomedicines12092157.
4
The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.循环生物标志物联盟：将 microRNAs 与游离 DNA 和蛋白质相结合。
Int J Mol Sci. 2024 Mar 17;25(6):3403. doi: 10.3390/ijms25063403.
5
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells.组织金属蛋白酶抑制剂-1 过表达介导三阴性乳腺癌细胞的化疗耐药性。
Cells. 2023 Jul 7;12(13):1809. doi: 10.3390/cells12131809.
6
Characterizing viscoelastic properties of human melanoma tissue using Prony series.使用普龙尼级数表征人类黑色素瘤组织的粘弹性特性。
Front Bioeng Biotechnol. 2023 Apr 6;11:1162880. doi: 10.3389/fbioe.2023.1162880. eCollection 2023.
本文引用的文献
1
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer.异常激活的 OPN/整合素 αVβ3/FAK 信号通路导致 EGFR 突变型非小细胞肺癌对 EGFR-TKI 耐药。
J Hematol Oncol. 2020 Dec 7;13(1):169. doi: 10.1186/s13045-020-01009-7.
2
Bone morphogenetic protein 7 promotes resistance to immunotherapy.骨形态发生蛋白 7 促进对免疫疗法的抵抗。
Nat Commun. 2020 Sep 24;11(1):4840. doi: 10.1038/s41467-020-18617-z.
3
Effect of Serum SPARC Levels on Survival in Patients with Digestive Tract Cancer: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial.血清富含半胱氨酸的酸性分泌蛋白水平对消化道癌患者生存的影响：AMATERASU随机临床试验的事后分析
Cancers (Basel). 2020 Jun 4;12(6):1465. doi: 10.3390/cancers12061465.
4
A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.S100A14-CCL2/CXCL5 信号轴驱动乳腺癌转移。
Theranostics. 2020 Apr 27;10(13):5687-5703. doi: 10.7150/thno.42087. eCollection 2020.
5
SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.SRGN 通过调节 HDAC2 的表达与 YAP 相互作用，维持乳腺癌细胞的化疗耐药性和干性。
Theranostics. 2020 Mar 4;10(10):4290-4307. doi: 10.7150/thno.41008. eCollection 2020.
6
Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway.分泌型丙酮酸激酶 M2 通过激活整合素 β1/FAK 信号通路促进肺癌转移。
Cell Rep. 2020 Feb 11;30(6):1780-1797.e6. doi: 10.1016/j.celrep.2020.01.037.
7
A framework for advancing our understanding of cancer-associated fibroblasts.推进我们对癌症相关成纤维细胞理解的框架。
Nat Rev Cancer. 2020 Mar;20(3):174-186. doi: 10.1038/s41568-019-0238-1. Epub 2020 Jan 24.
8
Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.碱性成纤维细胞生长因子通过影响 XRCC5 的表达促进软骨肉瘤细胞对阿霉素的耐药性。
Mol Carcinog. 2020 Mar;59(3):293-303. doi: 10.1002/mc.23153. Epub 2020 Jan 8.
9
Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.蛋白聚糖核心蛋白聚糖通过其糖胺聚糖与 CD44 的相互作用促进非小细胞肺癌细胞迁移。
J Biomed Sci. 2020 Jan 2;27(1):2. doi: 10.1186/s12929-019-0600-3.
10
Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.半乳糖凝集素-1 驱动的肿瘤内皮细胞中的 T 细胞排斥作用促进了免疫治疗抵抗。
J Clin Invest. 2019 Dec 2;129(12):5553-5567. doi: 10.1172/JCI129025.
Zotero 插件